Econ Healthcare (Asia) (Catalist:EHG) Full Year 2023 Results

Key Financial Results

• Revenue: S$52.7m (up 35% from FY 2022).

• Net income: S$4.85m (up by S$4.50m from FY 2022).

• Profit margin: 9.2% (up from 0.9% in FY 2022). The increase in margin was driven by higher revenue.

• EPS: S$0.019 (up from S$0.001 in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Econ Healthcare (Asia) EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) exceeded analyst estimates by 45%.

The company's shares are up 2.8% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 2 warning signs for Econ Healthcare (Asia) (1 makes us a bit uncomfortable!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here